People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zurex Pharma, Inc. | — | Pharmaceuticals | Series A | $30.1M | $24.9M | 2014 |
Roy A. Morgan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roy A. Morgan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert B. Truitt | 1 | 6 |
| Frederick A. Robertson | 1 | 3 |
| Michael J. Liang | 1 | 2 |
| Andrew M. Morgan | 1 | 2 |
| Alexander M. Kasper | 1 | 2 |
| R Andrew Morgan | 1 | 2 |
| Gary J Lehman | 1 | 2 |
| Carmine J Durham | 1 | 2 |
| Robert Andrew Truitt | 1 | 1 |
| Michael A. Liang | 1 | 1 |
| Connie A. Curran | 1 | 1 |
| Roy Andrew Morgan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.